Related Experiment Videos

[Analysis of 4 clustered high risk acute flaccid paralysis cases in Shanxi Province in 2006]

Dong-mei Yan1, Yong Zhang, Dong-yan Wang

  • 1World Health Organization Western Pacific Region Regional Reference Polio Laboratory, State Key Laboratory for Molecular Virology & Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

Zhongguo Yi Miao He Mian Yi
|June 26, 2010
PubMed
Abstract

Insights

Four clustered acute flaccid paralysis (AFP) cases in Shanxi, China, were linked to type III vaccine-related poliovirus. Enhanced laboratory surveillance is crucial for timely poliovirus detection and prevention.

Area of Science:

  • Virology
  • Epidemiology
  • Molecular Biology

Context:

  • Analysis of four clustered high-risk acute flaccid paralysis (AFP) cases in Shanxi province, China, reported in 2006.
  • Investigation focused on the characteristics of type III poliovirus isolated from these AFP cases.

Purpose:

  • To analyze the epidemiology of the clustered AFP cases.
  • To characterize the VP1 gene of the type III poliovirus isolates.
  • To determine the relationship between the isolates and vaccine strains.

Summary:

  • Three of the four high-risk AFP cases were suspected as vaccine-associated paralytic poliomyelitis (VAPP).
  • VP1 sequencing identified the four isolates as type III vaccine-related poliovirus, closely matching the vaccine reference strain BJOPV3.
  • Phylogenetic analysis indicated the isolates were not significantly related, though three VAPP cases shared a specific nucleotide mutation (2637 C-->U) leading to an amino acid change.

Impact:

  • Highlights the need for strengthened laboratory surveillance for clustered high-risk AFP cases.
  • Emphasizes the importance of timely detection and prevention of poliovirus circulation.
  • Provides insights into the genetic characteristics of vaccine-related poliovirus in the context of AFP outbreaks.